Roleda, Grace M.
HRN: 18-39-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/13/2022
11/19/2022
IV
2.25gms
Q8
Hospital Acquired Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose